Pathogenic variants identified by whole-exome sequencing in 43 patients with epilepsy

[1]  J. Rakotomamonjy,et al.  Characterization of seizure susceptibility in Pcdh19 mice , 2020, Epilepsia.

[2]  J. Gécz,et al.  Disentangling the paradox of the PCDH19 clustering epilepsy, a disorder of cellular mosaics. , 2020, Current opinion in genetics & development.

[3]  R. Macdonald,et al.  Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes. , 2019, Brain : a journal of neurology.

[4]  Ethan M. Goldberg,et al.  Use of a Dynamic Genetic Testing Approach for Childhood-Onset Epilepsy , 2019, JAMA network open.

[5]  Yiping Shen,et al.  Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: the China experience , 2018, Genetics in Medicine.

[6]  Renan Valieris,et al.  Utility of trio-based exome sequencing in the elucidation of the genetic basis of isolated syndromic intellectual disability: illustrative cases , 2018, The application of clinical genetics.

[7]  S. Zuberi,et al.  Dravet syndrome and its mimics: Beyond SCN1A , 2017, Epilepsia.

[8]  Tobias Loddenkemper,et al.  Early-Life Epilepsies and the Emerging Role of Genetic Testing , 2017, JAMA pediatrics.

[9]  S. Zuberi,et al.  Advances in epilepsy gene discovery and implications for epilepsy diagnosis and treatment , 2017, Current opinion in neurology.

[10]  Asla Pitkänen,et al.  Advances in the development of biomarkers for epilepsy , 2016, The Lancet Neurology.

[11]  D. Kolbe,et al.  Reducing the Cost of the Diagnostic Odyssey in Early Onset Epileptic Encephalopathies , 2016, BioMed research international.

[12]  J. Conroy,et al.  Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansion , 2016, Epilepsia.

[13]  R. Scott,et al.  GABRB3 mutations: a new and emerging cause of early infantile epileptic encephalopathy , 2015, Developmental medicine and child neurology.

[14]  W. Chung,et al.  Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.

[15]  Eric Vilain,et al.  Clinical exome sequencing for genetic identification of rare Mendelian disorders. , 2014, JAMA.

[16]  Michael R. Johnson,et al.  Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies , 2014, The Lancet Neurology.

[17]  P. Curatolo,et al.  Epilepsy associated with autism and attention deficit hyperactivity disorder: Is there a genetic link? , 2014, Brain and Development.

[18]  Michael R. Johnson,et al.  De novo mutations in the classic epileptic encephalopathies , 2013, Nature.

[19]  L. Vissers,et al.  Point mutations as a source of de novo genetic disease. , 2013, Current opinion in genetics & development.

[20]  S. Tsuji,et al.  Identification of ATP1A3 Mutations by Exome Sequencing as the Cause of Alternating Hemiplegia of Childhood in Japanese Patients , 2013, PloS one.

[21]  D. Nordli.  Epileptic Encephalopathies in Infants and Children , 2012, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[22]  Birgit Zirn,et al.  Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study , 2012, The Lancet Neurology.

[23]  David B. Goldstein,et al.  De novo mutations in ATP1A3 cause alternating hemiplegia of childhood , 2012, Nature Genetics.

[24]  E. Funkhouser,et al.  Incidence and prevalence of epilepsy among older US Medicare beneficiaries , 2012, Neurology.

[25]  P. Striano,et al.  The genetics of monogenic idiopathic epilepsies and epileptic encephalopathies , 2012, Seizure.

[26]  J. Shendure,et al.  Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.

[27]  J. Kleinman,et al.  Spatiotemporal transcriptome of the human brain , 2011, Nature.

[28]  Caleb Davis,et al.  Exome Sequencing of Ion Channel Genes Reveals Complex Profiles Confounding Personal Risk Assessment in Epilepsy , 2011, Cell.

[29]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[30]  Seema M Jamal,et al.  Novel de novo PCDH19 mutations in three unrelated females with epilepsy female restricted mental retardation syndrome , 2010, American journal of medical genetics. Part A.

[31]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[32]  S. Jóźwiak,et al.  Tuberous sclerosis , 2008, The Lancet.

[33]  Naomichi Matsumoto,et al.  De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy , 2008, Nature Genetics.

[34]  Y. Maegaki,et al.  Early onset West syndrome with cerebral hypomyelination and reduced cerebral white matter , 2008, Brain and Development.

[35]  Michael Westerveld,et al.  Global cognitive function in children with epilepsy: A community‐based study , 2008, Epilepsia.

[36]  Arjen Brussaard,et al.  Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size , 2006, Proceedings of the National Academy of Sciences.

[37]  P. Crino,et al.  The tuberous sclerosis complex. , 2006, The New England journal of medicine.

[38]  J. DeFelipe,et al.  Correlation of transcriptome profile with electrical activity in temporal lobe epilepsy , 2006, Neurobiology of Disease.

[39]  William B Dobyns,et al.  Mutations in the Na+/K+-ATPase α3 Gene ATP1A3 Are Associated with Rapid-Onset Dystonia Parkinsonism , 2004, Neuron.

[40]  R. Siebert,et al.  Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. , 2002, Human molecular genetics.

[41]  D. Ledbetter,et al.  Clinical and molecular basis of classical lissencephaly: Mutations in the LIS1 gene (PAFAH1B1) , 2002, Human mutation.

[42]  W. Hauser,et al.  Autosomal dominant partial epilepsy with auditory features: Defining the phenotype , 2000, Neurology.

[43]  De novo mutations in epileptic encephalopathies , 2013 .

[44]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[45]  D. Kwiatkowski,et al.  Tuberous sclerosis. , 1994, Archives of dermatology.